Abstract: A cable treatment device including: an affixing device for reversibly securing to a circumference of a power cable a kinematic device having attachment structure for attaching to the affixing member, the kinematic device adapted to provide kinematic motion relative to the attachment structure, the kinematic motion being fully controllable through a plurality of force input connections, and a tooling device attached to the kinematic device, the tooling device adapted to receive said kinematic motion, wherein the kinematic device allows the tooling to move cross-sectionally relative to the extension of a power cable secured by the affixing device. Thereby, a well-controlled and reproducible process is achieved, employing a portable device being user friendly, while simultaneously reducing technician exposure to toxic particulates.

Abstract: The present invention relates to an interface-forming device (x60) and a method for providing an electrically conductive power transmission interface (x30) on the end surface of a power cable (xOO) having at least two separate wires (x02) being electrically conductive, the cable (xOO) further comprising a reactive compound different from the wires (x02) for providing further features to the power cable (xOO). The method comprises the steps of providing an end section of the power cable (xOO), the end section comprising wires (x02) having wire ends, the end section further having the reactive compound, and successively adding electrically conductive particulates (x67A) onto the end section by bringing the conductive particulates being dispersed in a carrier fluid of a different material than the conductive particulates into contact with the end section. Thereby, cable joining and terminations are achieved of a higher quality.

Abstract: Techniques are disclosed for calibration systems and methods for analyte detectors. In one example, a system may include a calibration device configured to operate with an analyte detector. The calibration device may include a chamber configured to receive a sample and pass at least a portion of the sample including analytes to the analyte detector for examination. The calibration device may further include a reservoir including a calibrant and configured to be selectively positioned in the chamber as the sample to provide the portion of the sample including the analytes to calibrate the analyte detector. Additional systems and related methods are provided.

Abstract: The present invention relates to a flexible laminate (1) of photovoltaic cells, comprising at least: —a layer of interconnected photovoltaic cells (3); and —a front layer (5) and a back layer (7) for encapsulating the layer of photovoltaic cells (3), said front encapsulation layer (5) and said back encapsulation layer (7) sandwiching the layer of photovoltaic cells (3), the front encapsulation layer (5) comprises at least one glass fiber fabric (51) and at least a first encapsulation resin (53) that comprises at least one polyolefin, and the back encapsulation layer (7) comprises at least one glass fiber fabric (71) and a second encapsulation resin (73). The present invention also relates to a method for producing such a flexible laminate (1).

Abstract: The current disclosure address a need in the art by providing methods and compositions for treating migraines and certain pain-related disorders with a combination therapy. Accordingly, aspects of the disclosure relate to a method for treating a migraine, post-traumatic headache, or chronic pain syndrome patient, the method comprising administering to the patient an effective amount of an insulin growth factor receptor (IGFR) activator and a calcitonin gene-related peptide (CGRP) inhibitor. Further aspects relate to a composition comprising insulin-like growth factor-1 (IGF-1) and a CGRP inhibitor. Also provided are methods for treating fibromyalgia or chronic fatigue syndrome in a patient, the method comprising administering to the patient an effective amount of an insulin growth factor receptor (IGFR) activator.

Abstract: A cable treatment device including: an affixing device for reversibly securing to a circumference of a power cable a kinematic device having attachment structure for attaching to the affixing member, the kinematic device adapted to provide kinematic motion relative to the attachment structure, the kinematic motion being fully controllable through a plurality of force input connections, and a tooling device attached to the kinematic device, the tooling device adapted to receive said kinematic motion, wherein the kinematic device allows the tooling to move cross-sectionally relative to the extension of a power cable secured by the affixing device. Thereby, a well-controlled and reproducible process is achieved, employing a portable device being user friendly, while simultaneously reducing technician exposure to toxic particulates.

Abstract: Techniques are disclosed for calibration systems and methods for analyte detectors. In one example, a system may include a calibration device configured to operate with an analyte detector. The calibration device may include a chamber configured to receive a sample and pass at least a portion of the sample including analytes to the analyte detector for examination. The calibration device may further include a reservoir including a calibrant and configured to be selectively positioned in the chamber as the sample to provide the portion of the sample including the analytes to calibrate the analyte detector. Additional systems and related methods are provided.

Abstract: The present invention relates to an interface-forming device (x60) and a method for providing an electrically conductive power transmission interface (x30) on the end surface of a power cable (xOO) having at least two separate wires (x02) being electrically conductive, the cable (xOO) further comprising a reactive compound different from the wires (x02) for providing further features to the power cable (xOO). The method comprises the steps of providing an end section of the power cable (xOO), the end section comprising wires (x02) having wire ends, the end section further having the reactive compound, and successively adding electrically conductive particulates (x67A) onto the end section by bringing the conductive particulates being dispersed in a carrier fluid of a different material than the conductive particulates into contact with the end section. Thereby, cable joining and terminations are achieved of a higher quality.

Abstract: A method for recognition and display of one or more inputs for a touch-screen device is disclosed herein. The method includes determining a magnitude of a detected input of a touch-screen portion of the touch-screen device; determining an area of the detected input of the touch-screen portion; and modifying a graphical representation of the detected input based on the area and magnitude of the detected input. An apparatus for implementing the method is also disclosed herein.

Abstract: The improved analyte collection device is adjustable between two separate and distinct configurations. The first configuration enhances analyte collection by precluding undesired gas flow from around the sampling device. The second configuration enhances analyte collection by extending and focusing gas flow into the sampling device. Additionally, the current invention provides methods for collecting analyte from the surface of objects or the atmosphere.

Abstract: A golf tee comprising parallel golf ball supporting fins extending from an elongated blade-like main body. The fins bend and flex with the rapid momentary expansion and compression of the golf ball due the impact from a golf club, thereby offering a clear and unimpeded exit channel for the golf ball. The elongated main body tapers to a point for easy insertion into the teeing ground and has large side surface areas for the clear display of logos and general indicia.

Abstract: The invention provides a binding system for a snowboard comprising a boot (2) and a boot receiving plate (4), the boot receiving plate (4) having at least one engagement element (6), and the boot (2) having at least one boot gripping element (3) wherein the or each boot gripping element (3) and the or each engagement element are operable for flexible respective co-engagement.

Abstract: Methods and compositions for selecting a patient suffering from endotoxemia for treatment with an endotoxin neutralizing agent are disclosed comprising: (a) determining the level of endotoxin in the patient's blood; and (b) comparing the endotoxin level in the patient's blood to a predetermined threshold endotoxin level to determine if the patient has elevated endotoxin levels. The methods can further comprise treating patients identified as having elevated levels of endotoxin with an endotoxin neutralizing therapy. The methods provide increased safety and a reduction in risk for critically ill patients.

Abstract: Methods for reducing the number of pathologic antibody producing B cells in a patient suffering from an autoimmune disease by administration of an anti-germline antibody are described. Methods for removing pathologic antibodies and B cells and plasma cells producing pathologic antibodies from the body of a patient suffering from autoimmune disease are provided, comprising contacting the blood or plasma of the patient with an immunoadsorbent having specific binding for an epitope present on germline antibodies, particularly VH4-34 antibodies, wherein said contacting results in the reduction in the amount of germline antibodies present in the blood or bone marrow or lymphoid tissue of the patient or the amount of germline antibody producing B cells present in the blood, lymphoid tissues or bone marrow of the patient. Methods for treating a patient suffering from a B cell cancer expressing cell surface germline antibodies by similar methods are also provided.

Abstract: Methods for treating Alzheimer's disease (AD) or dementia using a CD20 antibody are described. Articles of manufacture for use in such methods are also described.

Abstract: Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell killing are provided. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. Preferably, the cell surface antigen is associated with the cytoskeleton of the cell. A preferred polyvalent agent is an IgM, and enhanced cell wounding and killing can be provided by the addition of a crosslinking agent. At sublethal concentrations in vivo, the cell wounding antibodies permeabilize cells and dramatically enhance response to chemotherapeutic agents, even in patients refractory to the chemotherapeutic agents.

Abstract: Formulations and methods of treating human patients suffering from a condition characterized by lymphoid cancer, autoimmune disease or B cell hyperproliferation are disclosed, the treatment comprising administering (1) a cytotoxic amount of an antibody having specific binding for CDIM epitopes on a B cell, and (2) a cytotoxic agent, including a chemotherapeutic agent, radioactive isotope, cytotoxic antibody, immunoconjugate, ligand conjugate, immunosuppressant, cell growth regulator and/or inhibitor, toxin, or mixtures thereof, including agents that disrupt the cytoskeleton of B cells, particularly vinca alkaloids or colchicine.

Abstract: The invention provides a binding system for a snowboard comprising a boot (2) and a boot receiving plate (4), the boot receiving plate (4) having at least one engagement element (6), and the boot (2) having at least one boot gripping element (3) wherein the or each boot gripping element (3) and the or each engagement element are operable for flexible respective co-engagement.

Abstract: Methods are provided for treating or alleviating the symptoms of subjects with psychological disorders, metabolic disorders, chronic stress-related disorders, sleep disorders, conditions associated with sexual senescence, aging, or premature aging by treating such subjects with IGF either alone or complexed with IGFBP-3. Methods for increasing the levels of DHEA or DHEAS and treating or alleviating the symptoms of subjects with disorders characterized by low levels of DHEA or DHEAS by administering effective amounts of IGF alone or complexed with IGFBP-3 are also provided. Methods for increasing the level of T4 and treating or alleviating the symptoms of subjects with disorders characterized by low levels of T3 or T4 by administering effective amounts of IGF alone or complexed with IGFBP-3 are additionally provided.